Tran Capital Management, L.P. Bio Techne Corp Transaction History

Tran Capital Management, L.P.

$827 Million
Q3 2024

A detailed history of Tran Capital Management, L.P. transactions in Bio Techne Corp stock. As of the latest transaction made, Tran Capital Management, L.P. holds 4,000 shares of TECH stock, worth $301,520. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,000

Previous 4,000 -0.0%

Holding current value

$301,520

Previous $286,000 11.54%

% of portfolio

0.04%

Previous 0.03%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	BUY	$80.67 - $352.29 $242,010 - $1.06 Million	3,000 Added 300.0%	4,000 $331,000
Q1 2022 Apr 28, 2022	BUY	$353.85 - $487.79 $353,850 - $487,790	1,000 New	1,000 $433,000
Q2 2021 Jul 16, 2021	SELL	$387.35 - $450.26 $1.72 Million - $1.99 Million	-4,430 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$314.62 - $411.0 $23,596 - $30,825	-75 Reduced 1.66%	4,430 $1.69 Million
Q4 2020 Jan 26, 2021	SELL	$246.9 - $321.87 $1.33 Million - $1.74 Million	-5,400 Reduced 54.52%	4,505 $1.43 Million
Q3 2020 Nov 09, 2020	SELL	$232.22 - $282.96 $2.24 Million - $2.73 Million	-9,640 Reduced 49.32%	9,905 $2.45 Million
Q2 2020 Aug 12, 2020	BUY	$185.43 - $279.56 $1.79 Million - $2.69 Million	9,635 Added 97.23%	19,545 $5.16 Million
Q1 2020 May 13, 2020	BUY	$161.17 - $221.51 $630,174 - $866,104	3,910 Added 65.17%	9,910 $1.88 Million
Q4 2019 Feb 14, 2020	BUY	$189.68 - $222.09 $739,752 - $866,151	3,900 Added 185.71%	6,000 $1.32 Million
Q2 2019 Aug 12, 2019	BUY	$188.72 - $215.43 $396,312 - $452,403	2,100 New	2,100 $438,000

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.96B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tran Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tran Capital Management, L.P. with notifications on news.

Account

Tran Capital Management, L.P. Bio Techne Corp Transaction History